Sonoma Pharmaceuticals shareholders elect director, approve executive compensation and auditor

Sonoma Pharmaceuticals, Inc.

Dr. Jay Birnbaum elected Class II director with 123,034 votes for, 19,478 withheld.
Non-binding advisory vote to approve named executive officer compensation passed 112,548 for, 26,360 against, 3,604 abstain.
Ratification of Frazier & Deeter as auditor for FY ending March 31, 2026 passed with 702,484 for, 13,569 against, 2,416 abstain.
Adjournment proposal passed with 576,908 for, 140,513 against, 1,048 abstain.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.